Kevin Kline

[Kevin Kline @Theperfectlap70]

@bkfViking123 @LukesGood232195 On the original or secondary facility?
Guess it doesn’t matter the CRL is out there.

[Unicorn Biotech @unicornbiotech]

$UNCY

last review - ahead of PDUFA -
"The FDA indicated that, given the identified deficiencies, any label discussions between the FDA and the Company are precluded. The Company has responded to all FDA information requests and expects a final decision from the FDA by the PDUFA action date of June 28, 2025."

Today, ahead of 6/29 PDUFA -
Shilpa comments also consistent for last few quarters on timing

[zohm @zohmbastic]

$UNCY Unicycive Therapeutics initiated with a Buy at B. Riley Securities $22

[Kevin Kline @Theperfectlap70]

@Relic57647069 @surferbackpack Because?

[Kevin Kline @Theperfectlap70]

This seems really suspicious considering the rest of the analysts remain highly bullish

[AnaChart @anachartanalyst]

#BENCHMARK analyst Bruce Jackson who covers $UNCY has the current 2nd biggest #pricetarget movement on AnaChart (06-Apr-2026 (9AM)) by downgrading from $21 to $15 with a decrease in potential upside change from $14.07(203.03%) to $8.07(116.45%) with a rating of Speculative Buy

[Kevin Kline @Theperfectlap70]

$UNCY- outside of the political uncertainties I was suspecting some people would be moving into UNCY at the beginning of a new quarter to potentially boost their portfolio performance with an End of Quarter Catalyst.

[Kevin Kline @Theperfectlap70]

@VIPSheffTrades Been scooping up UNCY shares!

[Kevin Kline @Theperfectlap70]

@JoyfulWood If this holds after hours and the deal is fully subscribed to and announced tomorrow. I think we see .30 tomorrow

[Kevin Kline @Theperfectlap70]

@Spencee_24 @boogeymantradez @ZacksSmallCap I think silence is your answer

[Kevin Kline @Theperfectlap70]

@davidinsh12 @zohmbastic That’s the estimated stock price when it’s in a pretty mature state. You may know that, but point being, even up to and initially approved there is some good SP appreciation possible

[Kevin Kline @Theperfectlap70]

@FightingbackHD @foxlogistix Heck no, it will sell off in the .40 -.50 range. Which is still a solid gain

[Kevin Kline @Theperfectlap70]

@robsmusic2 There is a catalyst upcoming, but the financials I think is weighing on the stock in my opinion

[Kevin Kline @Theperfectlap70]

@TheOnlyRampart1 Fast track what? They already have it for the main drug.

[Kevin Kline @Theperfectlap70]

@JspDilution Getting tinier everyday

[Kevin Kline @Theperfectlap70]

@Opal_Chip @Retired30 Do you mind highlighting what you like in GUTS? Just a swing or something compelling on the horizon?

[Kevin Kline @Theperfectlap70]

@VIPSheffTrades Don’t beat yourself up. Does it suck, yes, but you do us all a great service with your DD and recommendations.

[Kevin Kline @Theperfectlap70]

@BrianBarga02 @VIPSheffTrades That’s an understatement

[Kevin Kline @Theperfectlap70]

@VIPSheffTrades Done, thank you! Let’s have a great year!

[Kevin Kline @Theperfectlap70]

@NToola9 @firebutworking I’m all out @ $4.40, so won’t wait around to see how it plays out.

[Kevin Kline @Theperfectlap70]

@firebutworking How is this virtually unchanged. The voucher alone is 85% of its current capitalization